Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib

Update Il y a 4 ans
Reference: NCT01478373

Woman and Man

Extract

The purpose of this study is to evaluate the efficacy and safety of Dovitinib in patients with gastrointestinal stromal tumors refractory and/or intolerant to Imatinib


Inclusion criteria

  • gastrointestinal stromal tumors


Links